Inhibition of matrix metalloproteinase-9 by interferons and TGF-β1 through distinct signalings accounts for reduced monocyte invasiveness

FEBS Letters

Volumn 579, Issue 25, 2005, Pages 5487-5493

  Nguyen, Juliette ^a   Knapnougel, Perrine ^a   Lesavre, Philippe ^a   Bauvois, Brigitte ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

IRF 1; MMP 9; PTK, signaling; STAT1; Transmigration

Indexed keywords

ENZYME ANTIBODY; GAMMA INTERFERON; GELATINASE B; INTERFERON; INTERFERON REGULATORY FACTOR 1; JANUS KINASE INHIBITOR; MATRIGEL; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TYRPHOSTIN;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; EXTRAVASATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; HUMANS; INTERFERONS; LAMININ; MATRIX METALLOPROTEINASE 9; MONOCYTES; PROTEIN TRANSPORT; PROTEOGLYCANS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26844509284     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.09.012     Document Type: Article

References (37)

1. W.A. Muller New mechanisms and pathways for monocyte recruitment J. Exp. Med. 194 2001 47 51
2. G. Klein, E. Vellenga, M.W. Fraaije, W.A. Kamps, and E.S. de Bont The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia Crit. Rev. Oncol. Hematol. 50 2004 87 100
3. C.E. Brinckerhoff, and L.M. Matrisian Matrix metalloproteinases: a tail of a frog that became a prince Nat. Rev. Mol. Cell. Biol. 3 2002 207 214
4. S.W. Krause, M. Rehli, M. Kreutz, L. Schwarzfischer, J.D. Paulauskis, and R. Andreesen Differential screening identifies genetic markers of monocyte to macrophage maturation J. Leukoc. Biol. 60 1996 540 545
5. P.D. Smith, C.L. Lamerson, H.L. Wong, L.M. Wahl, and S.M. Wahl Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function J. Immunol. 144 1990 3829 3834
6. H.G. Welgus, E.J. Campbell, J.D. Cury, A.Z. Eisen, R.M. Senior, S.M. Wilhelm, and G.I. Goldberg Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development J. Clin. Invest. 86 1990 1496 1502
7. E.J. Campbell, J.D. Cury, S.D. Shapiro, G.I. Goldberg, and H.G. Welgus Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases J. Immunol. 146 1991 1286 1293
8. I. Nelissen, E. Martens, P.E. Van den Steen, P. Proost, I. Ronsse, and G. Opdenakker Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy Brain 126 2003 1371 1381
9. W.C. Parks, C.L. Wilson, and Y.S. Lopez-Boado Matrix metalloproteinases as modulators of inflammation and innate immunity Nat. Rev. Immunol. 4 2004 617 629
10. G.A. Bannikov, T.V. Karelina, I.E. Collier, B.L. Marmer, and G.I. Goldberg Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide J. Biol. Chem. 277 2002 16022 16027
11. S. Zucker, J. Cao, and W.T. Chen Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment Oncogene 19 2000 6642 6650
12. H. Sato, and M. Seiki Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells Oncogene 8 1993 395 405
13. R. Gum, E. Lengyel, J. Juarez, J.H. Chen, H. Sato, M. Seiki, and D. Boyd Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences J. Biol. Chem. 271 1996 10672 10680
14. S. Shishodia, S. Majumdar, S. Banerjee, and B.B. Aggarwal Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1 Cancer Res. 63 2003 4375 4383
15. D.V. Jovanovic, J. Martel-Pelletier, J.A. Di Battista, F. Mineau, F.C. Jolicoeur, M. Benderdour, and J.P. Pelletier Stimulation of 92-kD gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis Arthritis Rheum. 43 2000 1134 1144
16. M. Chawla-Sarkar, D.J. Lindner, Y.F. Liu, B.R. Williams, G.C. Sen, R.H. Silverman, and E.C. Borden Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis Apoptosis 8 2003 237 249
17. K. Schroder, P.J. Hertzog, T. Ravasi, and D.A. Hume Interferon-gamma: an overview of signals, mechanisms and functions J. Leukoc. Biol. 75 2004 163 189
18. D.V. Kalvakolanu Alternate interferon signaling pathways Pharmacol. Ther. 100 2003 1 29
19. M. Zhou, Y. Zhang, J.A. Ardans, and L.M. Wahl Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8 J. Biol. Chem. 278 2003 45406 45413
20. P. Saren, H.G. Welgus, and P.T. Kovanen TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages J. Immunol. 157 1996 4159 4165
21. T. Tanigawa, R. Pai, T. Arakawa, K. Higuchi, and A.S. Tarnawski TGF-beta signaling pathway: its role in gastrointestinal pathophysiology and modulation of ulcer healing J. Physiol. Pharmacol. 56 2005 3 13
22. S.M. Wahl, J.B. Allen, B.S. Weeks, H.L. Wong, and P.E. Klotman Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes Proc. Natl. Acad. Sci. USA 90 1993 4577 4581
23. T. Tajirian, J.W. Dennis, and C.J. Swallow Regulation of human monocyte proMMP-9 production by fetuin, an endogenous TGF-beta antagonist J. Cell. Physiol. 185 2000 174 183
24. M.A. Karsdal, P. Hjorth, K. Henriksen, T. Kirkegaard, K.L. Nielsen, H. Lou, J.M. Delaisse, and N.T. Foged Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression J. Biol. Chem. 278 2003 44975 44987
25. P. Harris, and P. Ralph Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines J. Leukoc. Biol. 37 1985 407 422
26. B. Bauvois, J. Van Weyenbergh, D. Rouillard, and J. Wietzerbin TGF-beta 1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-gamma: dependence on alpha 5 beta 1 and beta 2 integrins Exp. Cell. Res. 222 1996 209 217
27. J.M. Turley, L.A. Falk, F.W. Ruscetti, J.J. Kasper, T. Francomano, T. Fu, O.S. Bang, and M.C. Birchenall-Roberts Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms Cell Growth Differ. 7 1996 1535 1544
28. J.E. Darnell Jr. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway J. Interferon Cytokine Res. 18 1998 549 554
29. B. Bauvois, J. Dumont, C. Mathiot, and J.P. Kolb Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons Leukemia 16 2002 791 798
30. J. Sanceau, D.D. Boyd, M. Seiki, and B. Bauvois Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B J. Biol. Chem. 277 2002 35766 35775
31. P. Scuderi, K.E. Sterling, A.B. Raitano, T.M. Grogan, and R.A. Rippe Recombinant interferon-gamma stimulates the production of human tumor necrosis factor in vitro J. Interferon Res. 7 1987 155 164
32. M. Miyazaki, M. Sakaguchi, I. Akiyama, Y. Sakaguchi, S. Nagamori, and N.H. Huh Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells Cancer Res. 64 2004 4155 4161
33. H.M. Seidel, P. Lamb, and J. Rosen Pharmaceutical intervention in the JAK/STAT signaling pathway Oncogene 19 2000 2645 2656
34. A. Lehtonen, S. Matikainen, and I. Julkunen Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages J. Immunol. 159 1997 794 803
35. Y.T. Xuan, Y. Guo, H. Han, Y. Zhu, and R. Bolli An essential role of the JAK-STAT pathway in ischemic preconditioning Proc. Natl. Acad. Sci. USA 98 2001 9050 9055
36. K. Ogawa, F. Chen, C. Kuang, and Y. Chen Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site Biochem. J. 381 2004 413 422
37. G.G. Vaday, H. Schor, M.A. Rahat, N. Lahat, and O. Lider Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes J. Leukoc. Biol. 69 2001 613 621